Boston Scientific Estimates 2024 Adjusted EPS Of $2.38-$2.42 Compared To Prior Guidance $2.29-$2.34 And Consensus Of $2.33
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific has updated its 2024 adjusted EPS guidance to a range of $2.38-$2.42, up from the prior guidance of $2.29-$2.34 and above the consensus estimate of $2.33.
July 24, 2024 | 10:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific has raised its 2024 adjusted EPS guidance to $2.38-$2.42, which is higher than both its previous guidance and the consensus estimate. This positive revision indicates strong expected performance.
The upward revision in EPS guidance suggests that Boston Scientific is expecting better-than-anticipated financial performance. This is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100